Emergency presentation and inpatient vulnerability in sinonasal malignancies: National evidence of a diagnostic delay phenotype.

W Wei Ju Lin (1University of California, Riverside School of Medicine, Internal Medicine, Riverside, United States) R Rishi Kumar Nanda (Touro University Nevada College of Osteopathic Medicine, Las Vegas, NV) D Daniel Thomas Jones (HCA Sunrise Health GME Consortium - MountainView Hospital, Las Vegas, NV) K Kyaw Zin Thein (3Comprehensive Cancer Centers of Nevada, Division of Hematology and Medical Oncology, Las Vegas, United States) S Shivaani Kummar R Rajat Thawani (Oregon Health & Sciences University, Portland, OR)

Abstract

e23248 Background: Sinonasal malignancies are rare, heterogeneous tumors characterized by nonspecific early symptoms and frequent diagnostic delay, leading to advanced disease at presentation. While outpatient management and multimodal therapy have been extensively reviewed, national inpatient presentation patterns and rescue outcomes remain poorly defined. Methods: A survey-weighted analysis of the National Inpatient Sample from 2016–2023 was performed, identifying adult hospitalizations with sinonasal malignancies (C30–C31) in any diagnosis position and excluding admissions with palliative care coding. A diagnostic delay phenotype was defined by nonelective admission accompanied by acute organ failure at presentation, including sepsis, shock, respiratory failure, or acute kidney injury. Outcomes included in-hospital mortality, ICU escalation, failure-to-rescue (death following a major complication), length of stay, hospitalization cost, and discharge disposition. Outcomes were contextualized through comparisons with other rare cancers and common malignancies. Results: Sinonasal malignancies accounted for 0.66% (95% CI, 0.64%–0.69%) of cancer hospitalizations and were predominantly nonelective at 57.16% (95% CI, 55.63%–58.69%). Acute organ failure at presentation occurred in 21.53% (95% CI, 20.34%–22.72%) of sinonasal admissions, with sepsis in 7.70% (95% CI, 6.93%–8.46%) and respiratory failure in 8.77% (95% CI, 7.98%–9.56%). Overall in-hospital mortality was 1.64% (95% CI, 1.33%–2.02%). Among admissions with major complications, failure-to-rescue mortality was 4.23% (95% CI, 3.39%–5.27%). ICU escalation occurred in 4.93% (95% CI, 4.33%–5.52%), with post-ICU mortality of 27.74% (95% CI, 26.25%–29.27%). Compared with common cancers, sinonasal malignancies demonstrated higher rates of nonelective admission and acute organ failure but similar overall mortality, indicating preserved rescue despite high-acuity presentation. Conclusions: Sinonasal malignancies exhibit a distinct inpatient diagnostic delay phenotype marked by emergency presentation and acute organ failure at admission. Despite high physiologic acuity, inpatient mortality and failure-to-rescue are not disproportionately worse, suggesting that delayed recognition primarily shifts how patients present rather than whether they survive hospitalization. These findings complement existing clinical literature by identifying inpatient presentation and rescue as critical, understudied dimensions of sinonasal cancer care.

Article Details

Volume / Issue Vol. 44, Issue 16_suppl
Published June 01, 2026
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (6)

W

Wei Ju Lin

1University of California, Riverside School of Medicine, Internal Medicine, Riverside, United States

R

Rishi Kumar Nanda

Touro University Nevada College of Osteopathic Medicine, Las Vegas, NV

D

Daniel Thomas Jones

HCA Sunrise Health GME Consortium - MountainView Hospital, Las Vegas, NV

K

Kyaw Zin Thein

3Comprehensive Cancer Centers of Nevada, Division of Hematology and Medical Oncology, Las Vegas, United States

S

Shivaani Kummar

R

Rajat Thawani

Oregon Health & Sciences University, Portland, OR